CHCHD10

From WikiMD's WELLNESSPEDIA

CHCHD10 is a gene that encodes the mitochondrial protein CHCHD10. This protein is involved in the regulation of mitochondrial dynamics, including fusion and fission, and is essential for maintaining mitochondrial integrity. Mutations in the CHCHD10 gene have been associated with several neurodegenerative diseases, including frontotemporal dementia, amyotrophic lateral sclerosis, and spinal muscular atrophy.

Location of the CHCHD10 gene on human chromosome 22.

Structure[edit]

The CHCHD10 gene is located on the short (p) arm of chromosome 22 at position 13.33. The gene spans approximately 15 kilobases and consists of four exons. The encoded protein is 142 amino acids in length and contains a coiled-coil domain and a CHCH domain.

Function[edit]

The CHCHD10 protein is localized in the mitochondrial intermembrane space and is involved in the regulation of mitochondrial dynamics. It plays a crucial role in maintaining mitochondrial integrity by participating in the process of mitochondrial fusion and fission. The protein also has a role in the regulation of mitochondrial cristae morphology and in the maintenance of mitochondrial DNA.

Clinical significance[edit]

Mutations in the CHCHD10 gene have been associated with several neurodegenerative diseases. These include frontotemporal dementia, amyotrophic lateral sclerosis, and spinal muscular atrophy. The mutations lead to the production of a faulty CHCHD10 protein that cannot properly regulate mitochondrial dynamics, leading to mitochondrial dysfunction and, ultimately, neuronal death.

Research[edit]

Research into the CHCHD10 gene and its associated diseases is ongoing. Current research focuses on understanding the exact mechanisms by which mutations in the CHCHD10 gene lead to neurodegenerative diseases and on developing potential therapeutic strategies.


See also[edit]

References[edit]











Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.